The ROE as of November 2024 (TTM) for AIM ImmunoTech Inc. (AIM) is -256.33%

According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current ROE is -256.33%. This represents a change of 232.80% compared to the average of -77.02% of the last 4 quarters.

AIM ImmunoTech Inc. (AIM) Historical ROE (quarterly & annually)

How has AIM ROE performed in the past?

The mean historical ROE of AIM ImmunoTech Inc. over the last ten years is -96.36%. The current -256.33% ROE has changed 166.03% with respect to the historical average. Over the past ten years (40 quarters), AIM's ROE was at its highest in in the March 2021 quarter at -5.04%. The ROE was at its lowest in in the December 2023 quarter at -122.88%.

AIM ImmunoTech Inc. (AIM) ROE by Quarter and Year

Discovering the peaks and valleys of AIM ImmunoTech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AIM ImmunoTech Inc. (AIM) Average ROE

How has AIM ROE performed in the past?

The current ROE of AIM ImmunoTech Inc. (AIM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AIM ImmunoTech Inc. (AIM) ROE vs. Peers

How is AIM’s ROE compared to its peers?

AIM ImmunoTech Inc.’s ROE is greater than Aptorum Group Limited (-12.10%), greater than Applied Molecular Transport Inc. (-218.56%), greater than Fresh Tracks Therapeutics, Inc. (-14.73%), less than BioCardia, Inc. (526.79%), greater than Virax Biolabs Group Limited (-115.10%), greater than Blue Water Vaccines, Inc. (-111.44%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Hillstream BioPharma, Inc. (-47249.59%), less than Kiora Pharmaceuticals, Inc. (15.57%), greater than Forte Biosciences, Inc. (-117.85%), greater than Cellectar Biosciences, Inc. (-732.97%), greater than Diffusion Pharmaceuticals Inc. (-55460.19%), greater than Tonix Pharmaceuticals Holding Corp. (-158.27%), greater than Onconova Therapeutics, Inc. (-144.95%), greater than Jaguar Health, Inc. (-354.93%), greater than Vaxart, Inc. (-114.19%), greater than VBI Vaccines Inc. (-1081.80%), greater than Pulmatrix, Inc. (-61.78%), greater than Capricor Therapeutics, Inc. (-220.26%), less than Akari Therapeutics, Plc (1.04%), greater than Soleno Therapeutics, Inc. (-43.25%),

Build a custom stock screener for AIM ImmunoTech Inc. (AIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AIM ImmunoTech Inc. (AIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.